{
    "clinical_study": {
        "@rank": "60549", 
        "acronym": "ARGENTUM", 
        "arm_group": [
            {
                "arm_group_label": "Nanocrystalline silver", 
                "arm_group_type": "Experimental", 
                "description": "Flexible polyester low-grip coated nanocrystalline silver dressing. The dressing was applied to the lesion after being soaked in sterile distilled water. About this compresses to bandage movements will have been added and comes to avoid tourniquet bandage on-site maintenance, temperature of the affected area, cushioning and absorption of wound exudate when present. Is finished with the application of crepe bandages in the form of flakes containment curative and maintenance of pressure. This procedure aids in the bloodstream, and avoids the increased edema. The bandage is started from the periphery to the central region, avoiding tourniquet. The exchanges were performed every three days."
            }, 
            {
                "arm_group_label": "Silver sulphadiazine", 
                "arm_group_type": "Active Comparator", 
                "description": "Ranges for rayon containing cream 1% silver sulphadiazine were used. Involving this layer bandages for dressings were added in movements back and forth to avoid the tourniquet, providing maintenance of the temperature of the affected area, cushioning and absorption of wound exudate when present. This application was completed with crepe bandages to contain the dressing and maintain pressure. This procedure aids in the bloodstream, and avoids the increased edema. The bandage is started from the periphery to the central region, scales, avoiding the tourniquet. Dressing changes were performed daily."
            }
        ], 
        "brief_summary": {
            "textblock": "The evidence is insufficient to determine whether the types of dressings containing silver\n      differ as the time/proportion to complete healing of the wound and pain. We will analyse\n      cost-effectiveness of these dressings in outpatients, considering the service provided by\n      the National Public Health System."
        }, 
        "brief_title": "Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Second-degree Burn", 
        "condition_browse": {
            "mesh_term": "Burns"
        }, 
        "detailed_description": {
            "textblock": "Clinical trial, controlled, randomized, containing two parallel arms, the single center.\n\n      Adult patients between 18 and 65 years, regardless of sex, with second degree burns treated\n      in an outpatient setting without the need for surgical treatment will be randomized (1:1)\n      into two groups: silver sulfadiazine 1% on healing and the base nanocrystalline silver.\n      Primary endpoints include time to complete epithelialization of the wound / proportion of\n      lesions completely epithelialized over a period (15 days) specified time and change the\n      surface area of the lesion with the passage of time / proportion of lesions epithelialized\n      part in a specified period of time (15 days). Secondary outcomes include the number of\n      dressing changes and the level of pain associated with your application and removal; direct\n      medical costs and non-medical, need for surgery, incidence of infection and presence of\n      adverse events."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults between 18 and 65 years, regardless of sex and race, were included in the\n             study when they had second degree burns (partial thickness), ie, involving the\n             epidermis and part of the dermis, with at least the preservation of some dermal\n             appendages from of which the wound may possibly be epithelialized spontaneously\n             (ARTZ; Moncrief; PRITT, 1980) that required treatment in an outpatient setting\n             without the need for surgical debridement of devitalized tissue and skin\n             grafts-informed in the initial clinical diagnosis.\n\n        Exclusion Criteria:\n\n        - We excluded patients with diabetes, pregnant women, mentally disabled, with burns to the\n        face or face and hands before the planting of the feet, as it was felt that there is need\n        for specific treatment to prevent functional sequelae. Patients who have already started\n        treatment at other institutions, those who arrived after the 5th day of the burn or unable\n        to sign the consent form or who declined to participate."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02108535", 
            "org_study_id": "UNISO-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nanocrystalline silver", 
                "description": "Flexible polyester low-grip coated nano-crystalline silver layer. The level of silver is 1.64 mg/ cm\u00b2. This dressing enables the sustained release of silver in humid conditions dynamically and reached a higher plateau than 60mg/ L in less than 2 hours, and maintains a uniform level by 72 hours.", 
                "intervention_name": "Nanocrystalline silver", 
                "intervention_type": "Drug", 
                "other_name": "Acticoat"
            }, 
            {
                "arm_group_label": "Silver sulphadiazine", 
                "description": "This is at  Standard treatment. The cream silver sulphadiazine at 1% was applied on the burn aseptically in a thick layer, approximately 3 to 5 mm, ie 5 g per 80 cm2", 
                "intervention_name": "Silver Sulphadiazine", 
                "intervention_type": "Drug", 
                "other_name": "Silvazine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Silver Sulfadiazine", 
                "Sulfadiazine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "burns", 
            "dressings", 
            "silver sulfadiazine", 
            "silver compounds", 
            "cost"
        ], 
        "lastchanged_date": "April 5, 2014", 
        "location": {
            "contact": {
                "email": "silviamoreira@terra.com.br", 
                "last_name": "Silvia S Moreira, MSc"
            }, 
            "contact_backup": {
                "email": "mah-camargo@hotmail.com", 
                "last_name": "Mayara C Camargo, Nurse"
            }, 
            "facility": {
                "address": {
                    "city": "Sorocaba", 
                    "country": "Brazil", 
                    "state": "Sao Paulo", 
                    "zip": "18030-083."
                }, 
                "name": "Clinic of the Burn Treatment of Sorocaba's Hospital Complex"
            }, 
            "investigator": {
                "last_name": "Silvia S Moreira, Msc", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns", 
        "overall_contact": {
            "email": "silviamoreira@terra.com.br", 
            "last_name": "Silvia S Moreira, Doctor", 
            "phone": "+5515997785104"
        }, 
        "overall_contact_backup": {
            "email": "mah-camargo@hotmail.com", 
            "last_name": "Mayara C de  Camargo, Nurse", 
            "phone": "+5515997215236"
        }, 
        "overall_official": {
            "affiliation": "UNISO", 
            "last_name": "Luciane C Lopes, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "proportion of healed burns in the specific period", 
            "measure": "complete healing of wound", 
            "safety_issue": "No", 
            "time_frame": "15 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02108535"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sorocaba", 
            "investigator_full_name": "Luciane Cruz Lopes", 
            "investigator_title": "Professor - Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "the number of dressing changes in the patients", 
                "measure": "Number of dressing changes", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "The medical cost of the treatment comparing all dressing", 
                "measure": "Direct medical costs of treatment", 
                "safety_issue": "No", 
                "time_frame": "15 days"
            }, 
            {
                "description": "Level of pain associated with the application and removal of dressings", 
                "measure": "pain", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "the necessity of surgery;", 
                "measure": "sugery", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Incidence of infection", 
                "measure": "infection", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "any adverse events from silver dressing", 
                "measure": "adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }
        ], 
        "source": "University of Sorocaba", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sorocaba", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}